---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-097086"
form_type: "8-K"
ticker: null
cik: "0001834645"
company_name: "Peak Bio, Inc."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:24:25.939149+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Peak Bio appoints Sandip Patel as director and Audit Committee chair

## Summary
- Sandip Patel appointed as Class III director and Audit Committee chair effective August 8, 2024.
- Patel participated in May and July 2024 financings totaling $275,500.
- He brings experience in biotech M&A and finance; previously served as General Counsel at WellCare.
- No family relationships or arrangements with other directors or officers.
- Board cites his advisory background in biopharma for appointment.

## SEC filing metadata
- accession: 0000950170-24-097086
- form_type: 8-K
- cik: 0001834645
- company_name: Peak Bio, Inc.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834645/000095017024097086/0000950170-24-097086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834645/000095017024097086/pkbo-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-097086
- JSON: https://secwatch.observer/filing/0000950170-24-097086.json
- Plain text: https://secwatch.observer/filing/0000950170-24-097086.txt

## Key facts
- Executive change
  Sandip Patel was appointed as Class III Director and Audit Committee Chair at Peak Bio, Inc..
  - Action: appointed
  - Role: Class III Director and Audit Committee Chair
  source text: On August 8, 2024, the Board of Directors of Peak Bio, Inc. (the “Company”) appointed Sandip Patel as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834645/000095017024097086/0000950170-24-097086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.